Depomed Announces Second-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Depomed (DEPO) Tops Q2 EPS by 3c, Updates Guidance
August 8, 2018 7:35 AM EDTDepomed (NASDAQ: DEPO) reported Q2 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $63.3 million versus the consensus estimate of $63.8 million.
Guidance:
The Company is increasing its full-year adjusted EBITDA range to $145 million to... More
